Charles River Laboratories International, Inc.
(NYSE : CRL)

( )
CRL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -3.73%80.507.5%$327.87m
EFXEquifax, Inc. 0.15%185.122.0%$158.93m
CPRTCopart, Inc. 0.35%113.274.4%$141.77m
FLTFLEETCOR Technologies, Inc. 0.46%218.493.8%$130.30m
CRLCharles River Laboratories International, Inc. 0.02%226.314.4%$116.86m
BAHBooz Allen Hamilton Holding Corp. 0.07%89.542.1%$96.93m
CLVTClarivate Plc 0.00%14.650.0%$82.84m
CHGGChegg, Inc. 0.57%19.3515.1%$62.90m
MEDPMedpace Holdings, Inc. 0.00%153.891.0%$59.92m
WEWeWork, Inc. 2.75%6.360.0%$54.25m
TAXLiberty Tax, Inc. Class A 0.57%39.022.5%$53.20m
FOURShift4 Payments, Inc. 0.29%37.650.0%$50.87m
GGenpact Ltd. 0.35%43.327.1%$50.60m
TALTAL Education Group -0.20%4.950.6%$50.08m
PAGSPagSeguro Digital Ltd. 0.09%11.150.0%$46.17m

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment consists of the commercial production and sale of research models, research products, and the provision of services related to the maintenance and monitoring of research models and the management of the clients’ research operations. The Discovery and Safety Assessment segment offers integrated drug discovery services directed at the identification, screening, and selection of a lead compound for drug development and offers safety assessment services, including bioanalysis, drug metabolism, pharmacokinetics, toxicology, and pathology. The Manufacturing Support segment consists of Microbial Solutions, which provides in vitro (non-animal) lot-release testing products, microbial detection products, and species identification services, Biologics Solutions, which performs specialized testing of biologics as well as contract development and manufacturing, and Avian Vaccine Services, which supplies specific-pathogen-free chicken eggs and chickens. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.